Correlation of serum TNF-α, IL-4 and sIL-2R levels with radiologic and clinical manifestations in active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 339s Year: 2003
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005
Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency Source: Eur Respir J 2015; 46: 277-280 Year: 2015
Serial change in serum KL-6 levels correlate with the pulmonary function variables in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Serum levels of chitotriosidase in pulmunary sarcoidosis Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008
Differences in serum levels of inflammatory markers, proteases and antiproteases in COPD patients with and without emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
High level of serum SP-D with normal range of KL-6 predicts a good prognosis of patients with fibrotic changes on HRCT Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Impact of captopril on the IL10 serum levels in experimental pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Sputum cellularity and IL-8 levels are related to clinical and pulmonary function abnormalities in patients with asbestosis Source: Eur Respir J 2006; 28: Suppl. 50, 692s Year: 2006
Relationship between Ca19.9 levels in bronchoalveolar lavage, neutrophilic alveolitis, pulmonary function tests and HRCT pattern in pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003
The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Serum KL-6 and SP-D as useful clinical indicators of interstitial changes and pulmonary functional abnormality in patients with Sjogren's syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation? Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021
Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018